✦ LIBER ✦

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

✍ Scribed by Jeffrey Vainshtein, Eyad Abu-Isa, Karin B Olson, Michael E Ray…

Book ID: 120696394
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 882 KB
Volume: 7
Category: Article
ISSN: 1748-717X
DOI: 10.1186/1748-717X-7-82

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urethral Sparing Intensity Modulated Rad

Urethral Sparing Intensity Modulated Radiation Therapy (US-IMRT) Is Not Shown To Improve Urinary Quality of Life (QOL) in Low Risk Prostate Cancer (PCa): Results of a Randomized Phase II Trial

✍ J.M. Vainshtein; E. Abu-Isa; K. Olson; M.E. Ray; H.M. Sandler; D. Normolle; C. P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Prospective Randomized Phase 2 Trial of

Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer

✍ Freytag, Svend O.; Stricker, Hans; Lu, Mei; Elshaikh, Mohamed; Aref, Ibrahim; Pr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 671 KB

Phase II Study of Long-Term Androgen Sup

Phase II Study of Long-Term Androgen Suppression With Bevacizumab and Intensity-Modulated Radiation Therapy (IMRT) in High-Risk Prostate Cancer

✍ Jacqueline Vuky; Huong T. Pham; Sarah Warren; Erika Douglass; Kasra Badiozamani; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Long-term Outcome of a Phase II Trial Co

Long-term Outcome of a Phase II Trial Combining in Situ Gene Therapy and Intensity Modulated Radiotherapy With or Without Hormonal Therapy for Prostate Cancer

✍ B.S. Teh; H. Ishiyama; B. Xu; G. Ayala; T. Wheeler; D. Kadmon; A.C. Paulino; A.I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Multimodal treatment for high-risk prost

Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

✍ Guttilla, Andrea; Bortolus, Roberto; Giannarini, Gianluca; Ghadjar, Pirus; Zatto 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 249 KB

USING ADJUVANT CHEMO-HORMONO-THERAPY AFT

USING ADJUVANT CHEMO-HORMONO-THERAPY AFTER RADICAL PROSTATECTOMUY FOR LOCALLY ADVANCED PROSTATE CANCER PATIENTS DOES NOT DELAY CONTINENCE RECOVERY AND HAS A LOW IMPACT ON QUALITY OF LIFE: RESULTS OF MORBIDITY EVALUATION IN PRO 05 PHASE II RANDOMIZED TRIAL

✍ Ploussard, Guillaume; Salomon, Laurent; Paule, Bernard; Allory, Yves; Vordos, Di 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB